Asset Details
Do you wish to reserve the book?
MEASLES IS ON THE RISE - AND COVID-19 COULD MAKE IT WORSE
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
MEASLES IS ON THE RISE - AND COVID-19 COULD MAKE IT WORSE
Do you wish to request the book?
MEASLES IS ON THE RISE - AND COVID-19 COULD MAKE IT WORSE
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
MEASLES IS ON THE RISE - AND COVID-19 COULD MAKE IT WORSE
2020
Overview
Many children in poor countries are lucky to get a single dose, however, which doesn't always lead to full protection in all who receive it. Because the virus is so contagious, 92-95% of a population needs to be fully immunized to ward off outbreaks. In Ukraine, after a child died of unrelated causes following a measles jab in 2008, vaccination coverage plummeted from 95% that year to 31% in 2016, says Robb Linkins, a measles specialist in the global immunization division at the US Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. A new vaccine delivery system being developed by two teams - one a collaboration between the CDC and the Georgia Institute of Technology and Micron Biomedical, both in Atlanta, and the other at Vaxxas, a biotech company based in Sydney, Australia - could be a \"game changer\" for measles control, says Cochi. [...]the measles patch has languished for lack of funding, he says, and has yet to reach clinical trials. [...]polio is eradicated, the world does not have the appetite or money to target another disease for extinction, Cochi says.
Publisher
Nature Publishing Group
Subject
